El tratamiento con quimioterapia hoy en pacientes HER2 negativo: el papel de la eribulina - page 37

Eribulin Mesilate: outline
Origins and Mechanisms of action
Classis Anti-mitotic efects
Non-mitotic Effects of Eribulin in the tumour biology
Clinical Development
Fase III trials
Pooled analysis
Real world evidence
Ongoing combination trials
1...,27,28,29,30,31,32,33,34,35,36 38,39,40,41,42,43
Powered by FlippingBook